Stockreport

FDA Accepts Ionis' (IONS) NDA for Rare Disease Drug Olezarsen [Yahoo! Finance]

Ionis Pharmaceuticals, Inc.  (IONS) 
Last ionis pharmaceuticals, inc. earnings: 2/26 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: ionispharma.com
PDF therapy olezarsen as a potential treatment for adults with familial chylomicronemia syndrome (FCS). The FDA granted priority review to this NDA. A filing designated as [Read more]